We investigated the effects of administration of Bifidobacterium prepara tions and commercially available Bifidus Yogurt on infantile intractable diarrhea. Fifteen patients with intractable diarrhea were treated from 1982 to 1985. These patients (11 boys and 4 girls) ranged in age from 1 month to 15 years (mean 2.5 years) and received antibiotic therapy for the treatment of such diseases as septicemia and respiratory tract infections. During treatment, waterly diarrhea appeared and lasted for 1 to 10 weeks (mean 25 days) with deterioration of the general condition. Conservative therapy such as diet control, infusion and drug therapy could not cure the diarrhea. The antibiotics used included cephems, penicillins and aminoglycocides. In most cases, abnormal microflora was ob served: Candida or Enterococcus often predominated with a marked decrease of anaerobes and aerobes in the stool flora. During the disease, we could not detect any pathogens or toxins responsible for the diarrhea. In all patients, the stool frequency and appearance were dramatically improved within 3 to 7 days after oral administration of Bifidobacterium preparations of bifidus yogurt. The intestinal microflora of all subjects also became normal with predominance of resident Bifidobacterium or administered B. breve.
Introduction
Pediatric intractable diarrhea includes diarrhea that satisfies all of the following conditions: underminable cause, intractable clinical course and high mortality rate.1,2
So-called intractable pediatric diarrhea, which was the subject of this study, resisted dietary therapy and treatment with transfusion and antidiarrheal agents, producing a deteriorating systemic condition that resulted in an intractable clinical course. However, we found hat treatment with Bifidobacterium preparations and bifidus yogurt had ex cellent clinical effects on this type of diarrhea. Herein we describe representative cases and discuss the mechanisms of these preparations as a cure for diarrhea. candida GS medium (Eiken Chemical Co., Tokyo) was used.
In the detection of pathogens from loose stools, Shigella, Salmonella and Yersinia were examined using SS medium (Nissui), Vibrio cholerae and Vibrio parahaemolyticus with TCBS medium (Eiken), and Campylobacter with Skirrow's medium (Nissui). At least five strains of Clostridium difficile and enteropathogenic Escherichia coli were examined from each specimen using CCFA medium6 and DHL medium (Nissui), re spectively, and the presence or absence of toxin production was examined for each bacterium. Cytotoxin and enterotoxin produced by C. difficile were examined using fecal material at 1:10 dilution and culture supernatant as follows: cytotoxin was deter mined by means of cytopathogenic effects (CPE) on HeLa cells and CPE neutraliza tion by anti-Clostridium sorderii antibody7 (kindly provided by Prof. Nakamura of Kanazawa University); enterotoxin was determined by means of reversed-passive latex agglutination using a kit for enterotoxin detection (kindly provided by Denka Biological Laboratories, Tokyo). Heat-labile toxin (LT) and heat-stable toxin (ST) of entero pathogenic E. coli were detected using a commercial kit for enterotoxin detection (Denka Biological Laboratories) and by intragastric administration into young mice,s respec tively.
Oral Administration of Viable Bacterial Preparations
Patients received a preparation (BBG-01) containing Bifidobacterium breve at 109/g, which was isolated from breast-fed healthy infants, and another preparation (BLG-B) containing both Lactobacillus casei at 1010/g and B. breve at 109/g. Bacteria contained in these viable bacterial preparations are all present in commercial dairy prod ucts. In addition to these preparations, some of the patients were given bifidus yogurt (commercial name: Milmil, Yakult Honsha, Tokyo) that contained B. breve, Bifido bacterium bifidum and Lactobacillus acidophilus at 1010/100ml, 1010/100ml and 100/100ml, respectively. These preparations were administered at a mean daily dose of 3 g (divided by 3). A daily amount of 60-600 ml of bifidus yogurt was combined in some of the patients, based on their respective clinical states. Table 1 shows the clinical results for the 15 patients who were given viable bacterial preparations. All these patients were being administered antibiotics for treatment of infections, none of which originated in the gastrointestinal tract, except for one case of Salmonella enteritis. The most frequently found infectious diseases in these patients were septicemia (two cases) and suspected septicemia (six cases), and respiratory in fections (four cases).
Results

Clinical Results
Peritonitis, furuncles and Salmonella enteritis were found in one case each. The antibiotics administered to the patients included cephems, penicillins Case 1 (1983) was a 2-year-old girl suffering from periodic granulocytopenia as an underlying disease. There were furuncles on her neck and external genitalia. The patient had fever two days before hospitalization, and although she received cefaclor (CCL) orally at 500 mg/day, she was not relieved, but had very severe watery diarrhea at a frequency of more than 14 times a day after hospitalization. Staphylococcus aureus and Pseudomonas aeruginosa were isolated from the external genitalia, which exhibited gangrenous lesions. Watery diarrhea at a rate of 14-17 times per day persisted for about one week, and was resistant dietary therapy such as prohibition of eating or drinking and administration of 1/2 cow milk. At this time, we started to give her the combina tion preparation BLG-B containing B. breve and L. casei. Although treatment with cephalothin (CET), gentamicin (GM) and piperacillin (PIPC) was continued, the frequency and state of defecations showed improvement at the fifth day of treatment with BLG-B and returned to normal at the seventh day (the day after discontinuation This patient was a 22-month-old boy in 1983. He was hospitalized for vomiting and the occurrence of diarrhea more than 14 times a day. Immediately after admission, drinking and eating were prohibited, and kanamycin syrup, lactase and commercially available Lactobacillus preparation were administered. He had ileus at the fifth day of hospitalization and developed septicemia at the 12th day. The patient was then treated with ampicillin (ABPC), gentamicin (GM) and cefazolin (CEZ). Klebsiella pneumoniae was detected in his blood. After the start of treatment for septicemia, This patient was a 3-month-old boy in 1985. His parturient conditions were com pletely normal, mature delivery occurred at the 42nd week of gestation and birthweight was 4,145g. Although he was bottle-fed, his suckling strength decreased, and vomiting and diarrhea occurred three months after birth. Therefore, he was hospitalized at a nearby hospital. At the time of admission, dehydration and almost shock-like symptoms were observed as well as fever and a strongly positive inflammatory reaction, suggesting septicemia. Cefmetazon (CMZ) at 300mg/day was given for two weeks. During this time, watery diarrhea occurring 10-20 times/day continued. Thereafter, diarrhea was reduced to 5-7 times/day for a short time but again increased to 8-10 times/day four months after birth. The boy was then transferred to another public hospital. At that time, so-called malabsorption syndrome was suspected due to his thin layer of subcuta neous fat. A combination of transfusion and 1/2 Bonlact (soy bean milk, Wakodo Co., Tokyo) with BBG-01 rapidly improved his fecal consistency and the frequency of de fecation. Normal feces was seen at the fifth day.
Changes in Enteric Flora
Enteric flora before the treatment with BBG-01 showed E. coli and Enterococcus, both at a level of 10.0, as the predominant bacteria; Pseudomonas aeruginosa was also detected at a level of 9.0. At that time, watery or soft stool was seen at a frequency of five times/day. At the fourth day of treatment with BBG-01, both Bacteroidaceae 
Discussion
The most common definition of intractable diarrhea in the pediatric field was put forth by Avery, et al.,1 who advocated the following criteria: 1) diarrhea continues for longer than two weeks; 2) it occurs within 3 months after birth; and 3) fecal cul tures performed more than 3 times show no evidence of causative organisms for the sion of deoxycholic acid and chenodeoxycholic acid into lithocholic acid. Needless to say, the amount of primary bile acids will be increased if this metabolic activity of anaerobes is suppressed by treatment with antibiotics. From the standpoint of bile acid induced diarrhea, it is especially noted that chenodeoxycholic acid plays an important role in the onset of diarrhea, due to its detergent effects causing injury to mucous epithelial cells.15
Since products of short chain fatty acids such as acetic acid, propionic acid and butyric acid result from the main energy metabolisms of enteric flora, the production of these organic acids is reduced as a consequence of the inhibition of activities of enteric anaerobes by treatment with antibiotics. It was revealed that short chain fatty acids in the large intestine usually facilitate absorption of Na+ and H2O.16 Therefore, it can be said that the inhibition of anaerobes in conjunction with treatment with antibiotics possibly reduces the production of these short chain fatty acids, resulting in malabsorp tion of water.
Mucin secreted from the large intestine is a very important source of carbon for enteric flora.17 Although mucin is usually decomposed quickly, this substance is ac cumulated in the intestinal tract at a high level if enteric flora is suppressed by treat ment with antibiotics, possibly inducing diarrhea as a result of elevated osmotic pres sure.18
The cecum of germ-free animals is greatly swelled by water retention.19 Treatment with antibiotics frequently causes the same phenomenon in germ-free animals. The inhibition of bile acid metabolism , organic acid fermentation and utilization of mucin decomposition seems to be closely related to water retention in the cecum of germ-free animals, resulting in the occurrence of diarrhea.
Our study revealed that viable bacterial therapy, mainly using bifidus preparations, quickly induced enteric flora to return to normal states, in which Bifidobacterium sp.
predominate. This meant that metabolic activities of enteric flora returned to physio logical conditions and the balance between the host and its enteric physiology returned to normal. For example, when enteric flora returns to normal, malabsorption of water and electrolytes is corrected through short chain fatty acids produced by the normal flora, resulting in a cure of diarrhea.
We used the following three kinds of viable bacterial preparations: B. breve alone; two species, B. breve and L. casei; and B. breve, B. bifidum and L. acidophilus. Because B. breve was a component common to the three preparations and because it pre dominated among the administered bacteria in all of our patients, B breve was thought to play the most important role in the cure of diarrhea.
We have so far discussed the mechanisms involved in the recovery of diarrhea from the viewpoint of normalization of abnormal enteric flora by viable bacterial pre parations. However, clinical symptoms were improved before the completion of enteric flora normalization in some of our patients. In other words, the normalization of enteric flora was not always correlated with improvement in clinical symptoms. There were very interesting clinical findings such as that, prior to the improvement of fecal states, borborygmus was decreased, abdominal pain was reduced, and systemic status was markedly improved, and that fecal consistency was improved preceding the normaliza tion of enteric flora in some patients. If fecal state improved after enteric flora was normalized in the recovery course of diarrhea treated with viable bacterial preparations, it could be said that physiological changes in the intestinal tract, which were induced by the normalization of enteric flora, were useful in the treatment of diarrhea. How ever, since some patients showed improvement of clinical symptoms before the comple tion of enteric flora normalization, other factors may be participating in the recovery of diarrhea besides those normalizing enteric flora. This point remains to be further investigated.
Enteric flora partially serves the physiological functions of its host through its me tabolic activities. With this in mind, we hope that clinicians keep a watchful eye on dangerous aspects of chemotherapy and on their countermeasures and treatments (in cluding the use of viable bacterial preparations). 
